Chemotherapy Devices Market Overview, SWOT Analysis And 2025 Forecast with Major Players Advanced Chemotherapy Technologies, Baxter International, Becton, Dickinson, B. Braun, Fresenius Kabi

Chemotherapy is administrated intravenously through a Venous Access Device (VAD). Various types of devices are available including cannula, catheters, and implanted ports. The choice of the device depends on the type of therapy a patient is going to have and physical condition of patient. A central venous access device (CVAD) is made of a non-irritant material, such as silicone, which can be left in place for several weeks or months. CVAD can be used to administer fluids and drugs and can also be used to take blood samples. The main sites for central venous access devices are the external and internal jugular, and sub-clavian veins. Other potential access sites include the cephalic vein in the deltopectoral groove, axillary vein, and femoral vein.d

The global chemotherapy devices market was valued at US$ 10.9 billion in 2017, and is expected to witness a CAGR of 7.7% over the forecast period (2018 – 2026).

Cancer is a leading cause of death worldwide. According to the World Health Organization (WHO) report, cancer is the second leading cause of death worldwide, and it was responsible for an estimated 9.6 million deaths in 2018. Increasing consumption of tobacco and alcohol, and rising geriatric population base play an important role in surging the cancer incidence rates. According to the Global Burden of Disease 2015 study, tobacco use is the most important risk factor for cancer and is responsible for around 22% of cancer deaths worldwide.

Request For Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/2231

Moreover, with the rising incidence of cancer the demand for its treatment is also increasing eventually driving the chemotherapy devices market growth. According to the National Cancer Institute (NCI), in 2016, an estimated 15.5 million cancer survivors were reported in the U.S. and the number is expected to increase to 20.3 million by 2026.

Chemotherapy Devices Market Restraints

Chemotherapy devices can cause some level of discomfort to patients. For instance, during insertion of a skin-tunnelled catheter or port, the needle or guide wire can scratch the top of the lung causing an air pocket. Sometimes there may be bruising at the site where the needle went into vein or there might be damage to an artery or nerve. Moreover, there is a risk of infection. The risk is typically between one to three in 100 cases but can be higher depending on many other factors, such as diagnosis or treatment. There is also a risk of a clot formation around the port. The CVAD can split or become damaged. It can become dislocated if no longer in the correct position, it needs to be removed. All these factors can decrease the use of chemotherapy devices eventually hampering the chemotherapy devices market growth.

Chemotherapy Devices Market - Regional Insights

On the basis of region, the global chemotherapy devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe chemotherapy devices market is expected to generate significant revenue share during the forecast period, owing to increasing government spending on chemotherapy procedures. According to the National Health Service (NHS) 2016 report, chemotherapy is the major investment within NHS England’s Specialised Commissioning, accounting for an estimated US$ 1.8 billion a year.

Asia Pacific chemotherapy devices market is anticipated to grow at highest CAGR, owing to increasing geriatric population and incidence of various cancer among regional population. According to the National Cancer Institute, around 57% of new cancer cases in 2012, were reported in emerging economies such as Central America and parts of Asia and Africa; 65% of cancer deaths also occurred in these regions. Furthermore, according to the WHO 2018 report, around 70% of deaths from cancer occur in low- and middle-income economies.

Key players operating in the global chemotherapy devices market include Advanced Chemotherapy Technologies, Baxter International, Becton, Dickinson, B. Braun, Fresenius Kabi, Halyard Health, ICU Medical, Moog Inc., Micrel Medical, Smiths Group, Terumo Corporation, and Zyno Medical

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2231

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com